CRISPR/Cas9-Based Genetic Screening to Study T-Cell Function.

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• T-cell-based cancer immunotherapies show promise but require a deeper understanding of T-cell activation mechanisms.
• The precise molecular regulation of T-cell receptor (TCR) signaling remains incompletely elucidated.
• Systematic methods are needed to dissect complex cellular signaling pathways.

Purpose of the Study:

• To detail the application of CRISPR/Cas9 screening for identifying novel regulators of TCR signaling.
• To provide a comprehensive protocol for CRISPR screening, from library design to data analysis.
• To establish a framework for studying immune cell activation.

Main Methods:

• Utilized the CRISPR/Cas9 gene-editing system for large-scale functional screening.
• Developed and employed a specific sgRNA library targeting genes involved in TCR signaling.
• Integrated genomic DNA sequencing for identifying genetic perturbations and downstream effects.

Main Results:

• Successfully implemented a CRISPR screen to identify key regulators within the TCR signaling pathway.
• The described methodology enables systematic discovery of molecular players in T-cell activation.
• Demonstrated the feasibility of adapting the CRISPR screening approach for other immune cell types.

Conclusions:

• CRISPR screening is a powerful tool for dissecting TCR signaling pathways and understanding T-cell activation.
• This approach facilitates the identification of potential targets for enhancing T-cell-based cancer immunotherapies.
• The protocol is adaptable for studying B cells, dendritic cells, and other immune cell signaling.